F

Ferring Pharmaceuticals

Develops peptide hormone-based medicines and therapies

Medical Science Liaison - Reproduktionsmedizin

Biology & BiotechConfirmed live in the last 24 hours
Full-timeKiel, GermanyNo salary listed

About the Job

Requirements

  • A degree in pharmacy, chemistry, biology, human medicine, or veterinary medicine, ideally with a doctorate, or a comparable qualification.
  • Ability to communicate complex scientific content appropriately for the audience and based on evidence.
  • Experience in the pharmaceutical environment and understanding of relevant healthcare structures.
  • Confident use of standard Microsoft Office programs and other digital tools.
  • Very good English and German language skills.

Responsibilities

  • Further develop and implement the medical strategy in reproductive medicine in close collaboration with marketing, sales, and market access, including responsibility for medical-scientific approvals.
  • Maintain the key opinion leader network to support scientific exchange, generate medical insights, and identify unmet medical needs.
  • Plan, develop, conduct, and oversee medical-scientific projects and studies for data generation.
  • Organize scientifically high-quality events, coordinate cross-functionally, select participating experts, and brief them.
  • Analyze current clinical study results, prepare them, and train and present on them internally and externally.
  • Conduct medical-scientific training for employees and continuously update training content.
  • Exchange information with international Ferring colleagues and contribute to joint projects as needed.
  • Plan and manage the budget available for medical-scientific activities in the territory.

Desired Qualifications

  • Experience in reproductive medicine.

About the Company

Ferring Pharmaceuticals

Develops peptide hormone-based medicines and therapies

Ferring Pharmaceuticals develops medicines that use the body's own peptide hormones, focusing on specialties such as reproductive health, gastroenterology, and urology. Its products range from hormone-based therapies to newer gene-based treatments, such as Adstiladrin for bladder cancer. The company achieves its solutions through research-driven development and manufacturing, including synthetic production of peptide hormones (historically oxytocin and vasopressin) and ongoing expansion of production and clinical programs. Ferring differentiates itself by remaining privately held to pursue a long-term research vision, growing through organic expansion and strategic acquisitions while maintaining a global footprint (over 100 countries, 7,000+ employees). Its goal is to advance therapies that leverage the body's biology to treat diseases more effectively, supported by a sustained investment in R&D and manufacturing, with a future focus on bioengineered and gene-based approaches.

Company size
5,001-10,000
Company stage
Debt Financing
Total funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950

Recently Posted Jobs

Explore more opportunities at Ferring Pharmaceuticals

See more jobs